Statistics were abundant during discussions and presentations from day 3 of the JP Morgan Healthcare Conference:
ISRG announces Q4 2024 sales jumped 25%
Venture capital funding for digital health companies boomed from $14.3B in 2020 to $29.2B in 2021 to $15.7B raised in 2022
Digital health companies peaked at 14,000 before the 2023 and 2024 VC divestment
Healthcare stocks saw a strong resurgence in equity and debt volumes alongside a slight decline in M&A volume in 2024 especially post-Labor Day
There were 18 IPOs across all of life sciences in 2024 (IPO Tracker - Life Sciences Perspectives | Life Sciences Perspectives). Largest:
Tempus AI TEM ($410.7M)
CG Oncology CGON ($380M)
Kyverna Therapeutics KYTX ($319M)
Bicara Therapeutics BCAX ($315M)
Talkspace announced a roll-out of AI-powered tools to help providers prep for sessions and guide client care between sessions
Medicare Advantage insurers Alignment Healthcare and Clover Health both reported increased membership growth by 35% and 27% YOY respectively
Quanterix shared details about their proposed acquisition of Akoya Biosciences
Comentarios